Risk factors for hospital admission and mortality in patients with influenza virus infection: a systematic review and meta-analysis
Older age, immune compromise, and chronic illness identify patients at highest influenza risk.
*Systematic review and meta-analysis of observational studies; Level 2 (OCEBM).
Citation
Gao Y, Liu M, Uyeki TM, et al. Risk factors for hospital admission and mortality in patients with influenza virus infection: a systematic review and meta-analysis. Lancet Respir Med. Published online September 8, 2026. doi:10.1016/S2213-2600(26)00195-5
Background
Influenza usually resolves without complications, but some patients require hospital care or die. This review was done to support updated World Health Organization guidance by clarifying which patients with seasonal influenza are at greatest risk.
Patients
2,150,518 patients of any age with laboratory-confirmed seasonal influenza from 63 observational studies. Excluded studies of only pandemic or animal-origin influenza, case-control studies, small studies, and studies without adjusted estimates.
Intervention
Presence of clinical risk factors.
Control
Absence of the same risk factor.
Outcome
Hospital admission among non-severe influenza; all-cause mortality among severe influenza.
Follow-up Period
Varied by study; recruitment years 2005 to 2024.
Results
| Patient group | Outcome | Key factor | Adjusted odds ratio |
|---|---|---|---|
| Non-severe influenza | Hospital admission | Cardiovascular disease | OR 2.72 (95% CI 1.24 to 5.94) |
| Non-severe influenza | Hospital admission | Immune compromise | OR 2.70 (95% CI 1.55 to 4.70) |
| Non-severe influenza | Hospital admission | Chronic respiratory disease | OR 2.24 (95% CI 1.90 to 2.64) |
| Severe influenza | Death | Secondary bacterial infection | OR 4.13 (95% CI 1.53 to 11.14) |
| Severe influenza | Death | Sepsis | OR 3.19 (95% CI 2.08 to 4.89) |
| Severe influenza | Death | Age 65 years or older | OR 2.47 (95% CI 2.21 to 2.75) |
OR=odds ratio; CI=confidence interval.
Analyses used adjusted study estimates. Results were consistent after excluding pandemic-era studies and studies with higher bias risk.
Limitations
Evidence was observational, so unmeasured confounding remains possible. Some risk factors relied on few studies, definitions varied, children were underrepresented, and results mainly reflect adult populations in Europe, North America, and Asia.
Funding
WHO and Chinese public grants; no reported funder role.
Clinical Application
Prioritize vaccination, early antivirals, and closer monitoring for influenza patients with these high-risk features.
Journal Club
Discussion questions and an EBM quiz for this paper. How to run a journal club →
Discussion
Sign in to join the discussion.
No comments yet. Be the first to share your thoughts.